Your session is about to expire
← Back to Search
Citicoline supplement for Healthy Subjects
Study Summary
This trial is testing whether citicoline, a supplement sometimes taken for cognitive enhancement, actually improves attention and cognition in healthy people compared to a placebo.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this experiment accept participants of legal age?
"As outlined in the inclusion criteria, this clinical trial has a lower-age limit of 35 years and an upper-age boundary of 75."
How many participants can the study accommodate in total?
"Affirmative. Clinicaltrials.gov data clearly states that this study, which was published on 8 September 2021, is still recruiting participants to fill out its 148-person roster at a single site."
Are there any open spots remaining in this clinical study?
"Affirmative, the information from clinicaltrials.gov affirms that this trial is actively recruiting participants. The study was first uploaded on 8th September 2021 and recently revised on 12th September 2021. This research seeks to enroll 148 volunteers at a single medical centre."
Could I be considered a participant in this research project?
"This trial is welcoming 148 individuals, aged 35 to 75 years old and deemed a healthy subject (hs), who meet the following requirements: Can comprehend study procedures, has given their informed consent for participation in this research, scores more than 24 on the MMSE, less than 15 on the CESD-R and below 81.25 or above 36.8 on Gradual CPT; additionally self-reports poor attention with no health conditions blocking them from fulfilling all of these criteria as indicated by medical history and regular lab test results."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger